⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 1, 2024Open Access

List of Supplementary Information from PRMT1 Sustains De Novo Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast Cancer

Takehiro Yamamoto Tetsu Hayashida Yohei Masugi Kiyotaka Oshikawa Noriyo Hayakawa Mai Itoh Chiyoko Nishime Masami Suzuki Aiko Nagayama Yuko Kawai Takako Hishiki Tomomi Matsuura Yoshiko Naito Akiko Kubo Arisa Yamamoto Yujiro Yoshioka Tomokazu Kurahori Misa Nagasaka Minako Takizawa Naoharu Takano Koji Kawakami Michiie Sakamoto Masatoshi Wakui Takushi Yamamoto Yuko Kitagawa Yasuaki Kabe Kenichi Horisawa Atsushi Suzuki Masaki Matsumoto Makoto Suematsu

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

List of Supplementary Information

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Yamamoto et al. (2024) studied this question.

synapsesocial.com/papers/68e712c7b6db64358768bc31 https://doi.org/10.1158/0008-5472.25515750

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1List of Supplementary Information from PRMT1 Sustains <i>De Novo</i> Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast Cancer2024
2Supplementary Methods and References from PRMT1 Sustains <i>De Novo</i> Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast Cancer2024
3Supplementary Methods and References from PRMT1 Sustains <i>De Novo</i> Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast Cancer2024
4Data from PRMT1 Sustains <i>De Novo</i> Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast Cancer2024
5PRMT1 Sustains <i>De Novo</i> Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast Cancer2024 · 59 citations